Home Tags Clinical trial

Tag: Clinical trial

Sample lifecycle in a human biobank

Utilizing Modular Biobanking Software in Different Types of Biobanking Activities

Abstract Biobanking defines all activities linked to bioresource management—whether of human, animal, microbial, or environmental origin—which means that any biobank information management system should take into account the multistep life cycle of the samples: from acquisition, through preparation, storage, to...
ATCC Awarded New Contract from the National Cancer Institute to Process Biomaterials for Cancer Research

ATCC Awarded New Contract from the National Cancer Institute to Process Biomaterials for Cancer...

ATCC, the world’s premier biological materials management and standards organization announced that it has been selected as an awardee for the National Cancer Institute’s (NCI) Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services contract. Under this contract, ATCC...
Monash launches flagship biological storage facility: Biobanking Victoria

Biobanking Victoria: Australia’s First Industry-Focused Flagship Biobank Launched by Monash University

Monash University has officially launched Australia’s first industry-focused storage facility for biological material to support medical research and commercialisation opportunities. Biobanking Victoria is a state-of-the-art facility that provides a valuable link between researchers and industry, generously supported by the Victorian...

Magenta Therapeutics Presented MGTA-456 At Transplant And Cellular Therapy (TCT) Annual Meeting

Magenta Therapeutics has announced that the company presented Phase 2 clinical data and preclinical research on its MGTA-456 program at the TCT annual meeting. Founded in 2015, headquartered in Cambridge, Massachusetts, USA, Magenta Therapeutics is a clinical-stage biotechnology company developing...

BrainStorm Cell Therapeutics Contracts Cleveland Clinic For Multiple Sclerosis Clinical Trial Site

BrainStorm Cell Therapeutics Inc., has announced that the Cleveland Clinic is the first U.S. clinical site contracted for a planned Phase 2 open-label, multicenter study of repeated intrathecal administration of autologous mesenchymal stem cells secreting neurotrophic factors (MSC-NTF) in...

Asterias Expands The Indication Exploration Scope For AST-OPC1 Cell Therapy

Asterias Biotherapeutics, Inc. is a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies to treat cancer. Asterias is presently focused on advancing three clinical-stage programs which have the potential to...

In-Home Clinical Services Enhanced By LabConnect And Symphony Clinical Research Partnership

LabConnect, LLC, was founded in 2002, providing a global central laboratory, biorepository and client-inspired support services which include routine specialized laboratory testing, kit building, sample management, and data management, serving biopharmaceutical, medical device, and Contract Research Organisation (CRO) clients....

⭐ Recently Featured

🔥 Popular Posts

X